Judith A. Aberg
0000-0001-8162-0284
Publication & Citation Trends
Publications
0 total
Post-transfusion activation of coagulation pathways during severe COVID-19 correlates with COVID-19 convalescent plasma antibody profiles OA
Cited by 0
Semantic Scholar
Humoral SARS-CoV-2 vaccine responses are durable in solid organ transplant recipients with and without HIV.
Cited by 0
Semantic Scholar
COVID-19 Breakthrough Infections in Severely Immunocompromised Patients Who Received Tixagevimab/Cilgavimab for Pre-exposure Prophylaxis
Cited by 0
Semantic Scholar
A Quality Improvement Pilot to Increase Hepatitis B Screening and Optimize Patient Selection for the Switch to Two-Drug Antiretroviral Regimens in People With HIV
Cited by 0
Semantic Scholar
Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort OA
Cited by 3
Semantic Scholar
High HIV-1 viremia and low anti-Env antibody responses are associated with delayed treatment response to fostemsavir in highly treatment-experienced individuals.
Cited by 0
Semantic Scholar
Clinical outcomes in immunocompromised adults with COVID-19, based on anti-spike IgG serostatus and monoclonal antibody therapy: a retrospective cohort study in the Omicron period OA
Cited by 1
Semantic Scholar
Research Topics
HIV-related health complications and treatments
(138)
HIV/AIDS drug development and treatment
(88)
HIV Research and Treatment
(79)
HIV/AIDS Research and Interventions
(78)
COVID-19 Clinical Research Studies
(47)
Affiliations
New York City Health and Hospitals Corporation
San Francisco General Hospital
National Institutes of Health
Albert Einstein College of Medicine
Pennsylvania State University